Company profile: Joinn Biologics
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services for biologics and advanced therapies, from early development to IND to commercial stage, including cell line development (proprietary and CHO-K1), master cell banking, upstream/downstream process and cGMP manufacturing, protein purification, and analytics to assess quality and impurities.
Products and services
- Process Development: Architects both upstream and downstream workflows to establish scalable, robust, and cost‑effective biotherapeutics manufacturing processes, using custom-engineered methodologies
- Upstream Manufacturing: Delivers cGMP-compliant production services from vial to final production vessel, leveraging a variety of cell culture production equipment and in‑process testing technologies
- Downstream Manufacturing: Executes protein purification using equipment reflecting the latest industry standards across various filtration and chromatography steps, enabling chromatography-grade downstream operations for biologics.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Joinn Biologics
CN Bio
HQ: United Kingdom
Website
- Description: Provider of human organ-on-a-chip platforms and services for drug discovery and disease research, including PhysioMimix OOC single- and multi-organ systems, PhysioMimix HT for higher-throughput R&D, contract research services, and liver and lung assays covering NASH, HBV, and COVID-19 for long-term culture, infection modeling, drug efficacy, safety testing, and immune response studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CN Bio company profile →
Precision NanoSystems
HQ: Canada
Website
- Description: Provider of tools and processes for developing and manufacturing nanoparticles for medicines and medical research, offering the NanoAssemblr benchtop instrument for nanoparticle prototyping and for developing nanoparticle-based drugs delivering RNA, small-molecule, and protein therapeutics, and Neuro9Kit to study gene function in neurons and glia cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precision NanoSystems company profile →
ReadyCell
HQ: Spain
Website
- Description: Provider of cell-based in vitro tools and drug discovery services, including: CacoReady, a ready-to-use Caco-2 kit for assessing intestinal permeability in preclinical studies; CacoGoblet, a Caco-2/HT-29 co-culture to evaluate intestinal absorption and anti-inflammatory drug efficacy; PreadyPort, MDCKII-based kits to study permeability and MDR1/BCRP efflux; PreadyTake, HEK293 transporter-overexpressing kits (MATE1, OCT2, OATP1B3).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ReadyCell company profile →
ChemoMetec
HQ: Denmark
Website
- Description: Provider of user-friendly instruments and software for precise cell counting and viability, including NucleoCounter NC-202 and NC-200 automated cell counters, XcytoMatic 40 for cell density analysis, Via2-Cassette disposable sampling cassettes, and NC-View/NucleoView image-analysis software, serving production/R&D, GMP, quality control, clinical diagnostics, cell therapy, and large pharmaceutical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemoMetec company profile →
Atomic Alchemy
HQ: United States
Website
- Description: Provider of radioisotopes for medical, research, exploration, and industrial use, aiming to establish a reliable domestic supply in the U.S. for medical radioisotopes such as molybdenum-99, in a market that currently lacks a dedicated domestic supplier and relies on university research reactors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atomic Alchemy company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Joinn Biologics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Joinn Biologics
2.2 - Growth funds investing in similar companies to Joinn Biologics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Joinn Biologics
4.2 - Public trading comparable groups for Joinn Biologics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →